Figure 6. Clarity, reduced cost and increased drug development transparency are trust builders for pharma companies
The ultimate healthcare experience: what people want · page 14 of 21
The chart displays 11 distinct categories of trust-building factors with corresponding percentages.
Consulting deck · data_table · analyze_data · overcrowded density
Slide locked Sign in to view
Slide schematic 7/9
callout 0/1 chart 1/1 metric 0/1 paragraph 4/4 source-note 1/1 title 1/1
2 without position callout 1 · metric 1
calloutmetric · primary
Components 9
callout bar-vertical primary paragraph paragraph paragraph paragraph source-note headline
Tools 5
Action Titles slide · 85%
Title spells out conclusion: 'Clarity, reduced cost and increased drug development transparency are trust builders for pharma'
Annotation slide · 85%Each bar carries inline % + descriptor label
Color Strategy slide · 60%Single-color bars rank-ordered for clean visual
Data Story Arc slide · 60%Overcoming the trust obstacle to drive digital health technology adoption requires three primary approaches:
Visual Hierarchy slide · 60%Bars descend by value to make top drivers obvious
Metrics 1
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.